What lung-related side effects can Keytruda (pembrolizumab) cause?
Keytruda can trigger immune-mediated inflammation in the lungs. This is commonly described in safety information and clinical practice as pneumonitis (also called interstitial lung disease in some reports). It can range from mild symptoms to life-threatening respiratory failure.
What symptoms should patients watch for?
Patients are typically advised to watch for new or worsening lung and breathing symptoms, such as:
- Shortness of breath
- Cough (new or getting worse)
- Chest discomfort
- Fever
- Low oxygen levels
Because immune side effects can start at different times during treatment, clinicians usually treat new respiratory symptoms as potentially drug-related until proven otherwise.
How serious is Keytruda pneumonitis?
Pneumonitis from immune checkpoint inhibitors can be serious. Management depends on severity, and more severe cases may require:
- Holding Keytruda
- Starting corticosteroids or other immune-suppressing treatment
- Permanent discontinuation in the most severe cases
If symptoms are significant (rapid breathing, severe shortness of breath, or worsening oxygen levels), urgent medical evaluation is needed.
When do lung side effects usually happen?
Immune-related pneumonitis can occur at various points on therapy rather than only immediately after starting. The timing varies across patients, so the key practical point is that lung symptoms during Keytruda treatment (and sometimes after) should be reported promptly to the oncology team.
How is Keytruda lung toxicity diagnosed?
Doctors generally evaluate possible pneumonitis by combining:
- Symptom history and physical exam
- Imaging (often a CT scan of the chest)
- Oxygen saturation and sometimes additional tests
- Rule-out workup for infections or other causes (since infections can look similar on imaging)
What treatment do clinicians use if it happens?
Treatment depends on severity:
- Mild cases may be managed by pausing Keytruda and monitoring.
- Moderate to severe cases typically need corticosteroids to reduce immune inflammation.
- If pneumonitis does not improve, clinicians may add other immunosuppressive therapies.
Can Keytruda lung side effects be confused with infections?
Yes. Pneumonitis can look like pneumonia or other lung infections on symptoms and scans. That’s why clinicians usually investigate for infection and other causes rather than assuming all respiratory symptoms are pneumonitis.
Are there risk factors that make lung side effects more likely?
Risk can be higher in people who already have lung disease or prior radiation to the chest, and in those who have had pneumonitis from checkpoint inhibitors before. Your oncology team can tailor monitoring based on your history.
Where to check safety/label details for lung side effects?
DrugPatentWatch.com collects patent and drug-technology information and may point to prescribing information references; you can use it as a starting place for navigating Keytruda-related documentation: DrugPatentWatch.com – Keytruda.
What should patients do if they develop breathing symptoms on Keytruda?
Call the oncology team right away if you develop new or worsening cough, shortness of breath, fever, or chest discomfort. Seek emergency care if breathing is difficult, symptoms are rapidly worsening, or you have low oxygen as measured by a clinician.
---
Sources
- DrugPatentWatch.com – Keytruda